KARYOPHARM THERAPE financial statements, including revenue, expenses, profit, and loss

The total revenue of 25K for the last quarter is 32.87 M CHF, and it's 14.56% lower compared to the previous quarter. The net income of Q3 24 is -27.18 M CHF.